1,5-dimethyl-2-phenyl-4-[(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)methyl]-1,2-dihydro-3H-pyrazol-3-one (4506-38-1)

Identification
Name:	1,5-dimethyl-2-phenyl-4-[(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)methyl]-1,2-dihydro-3H-pyrazol-3-one
Synonyms:	AC1ME0UK;Oprea1_384900;HMS1581K08;1,5-dimethyl-2-phenyl-4-[(3,3,5-trimethyl-7-azabicyclo[3.2.1]octan-7-yl)methyl]pyrazol-3-one;4506-38-1
CAS:	4506-38-1
Molecular Formula:	C₂₂H₃₁N₃O
Molecular Weight:	353.501
InChI:	InChI=1/C22H31N3O/c1-16-19(20(26)25(23(16)5)17-9-7-6-8-10-17)13-24-15-22(4)12-18(24)11-21(2,3)14-22/h6-10,18H,11-15H2,1-5H3
Molecular Structure:
Properties
Flash Point:	162.5°C
Boiling Point:	436.6°C at 760 mmHg
Density:	1.099g/cm³
Refractive index:	1.567
Flash Point:	162.5°C
Safety Data

Other Product

4(3H)-Quinazolinone,6-bromo-3-(1-methylethyl)-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
4(3H)-Quinazolinone,6-iodo-3-(1-methylethyl)-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
1H-Indol-5-ol,2-(4-hydroxyphenyl)-3-methyl-1-[[4-[2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)ethoxy]phenyl]methyl]-
4(3H)-Quinazolinone,5-fluoro-3-propyl-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
8-Azoniabicyclo[3.2.1]octane,3-[(hydroxydiphenylacetyl) oxy]-6-methoxy-8,8-dimethyl-,bromide,mixt. with 1,2-dihydro-1,5-dimethyl-4-(methylamino)- 2-phenyl-3H-pyrazol-3-one and 4-ethyl-1,2-dihydro-2-(1-methyl-4- piperidinyl)-5-phenyl-3H-pyrazol-3-one
Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3- methoxy-17-methyl-,(5R,6R)-,phosphate (1:1) (salt),mixt. with (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3- yl R-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt),sodium [(2,3-dihydro-1,5-dimethyl-3- oxo-2-phenyl-1H-pyrazol-4-yl)methylamino]- methanesulfonate and N,N,R-trimethyl-10H-phenothiazine-10- ethanamine monohydrochloride
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt), sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate and N,N,alpha-trimethyl-10H-phenothiazine-10-ethanamine
4(3H)-Quinazolinone,3-(2-propenyl)-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
Phenol, 3-(6-methyl-6-azabicyclo[3.2.1]oct-1-yl)-
3-(6-methyl-6-azabicyclo[3.2.1]oct-1-yl)phenol
1-phenyl-3-(1-phenyl-6-azabicyclo[3.2.1]oct-6-yl)propan-1-one hydrochloride
4(3H)-Quinazolinone,5-fluoro-3-(2-propenyl)-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
3-(6,8-dimethyl-6-azabicyclo[3.2.1]oct-1-yl)phenol
3-(6,8-dimethyl-6-azabicyclo[3.2.1]oct-1-yl)phenol
Benzenamine,4-[(1,8,8-trimethyl-3-azabicyclo[3.2.1]oct-3-yl)methyl]-, hydrochloride (1:2)
4-[1-(3-hydroxyphenyl)-6-azabicyclo[3.2.1]oct-6-yl]-1-phenylbutan-1-one hydrochloride
8-Azabicyclo[3.2.1]oct-3-en-2-one, 6-phenyl-8-(1-phthalazinyl)-, endo-
1-Butanone,4-[1-(3-hydroxyphenyl)-6-azabicyclo[3.2.1]oct-6-yl]-1-phenyl-,hydrochloride
4(3H)-Quinazolinone,6-iodo-3-(2-propenyl)-2-(1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl)-
8-Azabicyclo[3.2.1]oct-3-en-2-one, 8-(1-phthalazinyl)-6-(4-pyridinyl)-,endo-